revenue growth

Palantir beat Q1 earnings with 84% growth but fell 7% as investors grapple with extreme 94x P/E valuation, signaling growth alone cannot justify stretched multiples.

Six Flags stock surged 15.59% after reporting 12% revenue growth, 4% attendance gains, and a $48 million EBITDA improvement in Q1.

Becton Dickinson surges 5.9% after beating Q2 estimates with $4.71B revenue and raising full-year profit guidance to $12.52-$12.72 EPS.

$LAMR crushes Q1 with 7.7% EBITDA growth on 3.9% revenue expansion, signaling strong programmatic adoption and potential August guidance raise.

IonQ posts 755% YoY revenue growth to $64.7M but masks $96.8M adjusted EBITDA loss. Net income buoyed by $1.1B warrant valuation gain, not operations.

Standard Dental Labs closes BRLIT acquisition, boosting annualized revenue 375% to $1.1M from $236K as consolidation strategy advances.

Alpha Pro Tech reports Q1 2026 revenue of $14.6M (+5.5% YoY) with net income of $702K ($0.07 diluted share) amid tariff headwinds and building supply weakness.

Syra Health reports first profitable quarter with $241K net income, 22% revenue growth to $2.3M, and 11-point gross margin expansion amid strong population health momentum.

$LFST posts 21% YoY revenue growth to $403.5M, swings to $14.2M profit. Raises full-year guidance amid 11% clinician expansion.

Privia Health reported Q1 2026 revenue of $603.8M, up 25.8% YoY, with adjusted EBITDA rising 36.3%. Company raised attributed lives guidance to 1.6-1.625 billion.

Lamar Advertising exceeded Q1 forecasts with 7.7% EBITDA growth to $226.3M and $528M revenue, though net income fell due to prior-year asset sale comparison.

Microsoft and Meta show strong AI-driven revenue growth—Azure up 40%, Meta up 33%—despite investor concerns about heavy spending, positioning both as compelling long-term buys.

AI stocks rebounded strongly after early 2026 valuation pressures as tech giants demonstrated AI investments generate real customer commitments and revenue growth, validating the sector's long-term viability.

$DOCN rallies on 22% Q1 revenue growth and 221% ARR surge. Guidance raised to 50%+ growth, but 125X valuation and institutional selling raise correction risks.

Meta's Q1 revenue surged 33% YoY, but an $8.03B tax benefit inflated earnings. Adjusted EPS grew just 14%, while capex guidance nearly doubled to $125-145B.

OraSure posts 4% Q1 revenue growth to $27.9M with gross margin expansion to 42.3%, maintaining $177M cash. Two FDA submissions expected midyear clearance with 2027 breakeven guidance.

$SNWV expects Q1 revenue of $9.6-$9.7M, up 3-4% YoY. Company to discuss results May 13.

OTC Markets Group reports 14% Q1 2026 revenue growth to $34.8M, with operating income up 19% and EPS rising 18% to $0.59. Company returns $6.8M to shareholders and declares $0.30 dividend.

Supernus Pharmaceuticals reports strong Q1 2026 results with $207.7M revenue, up 39% YoY. CEO Jack Khattar to present at Bank of America health care conference in May.

Snap beat Q1 earnings estimates on revenue and profits while returning to user growth. Despite positive results, stock fell 4.26% after hours.